摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1R)-1-(4-methoxyphenyl)-2-<(1S)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl>ethanol

中文名称
——
中文别名
——
英文名称
(1R)-1-(4-methoxyphenyl)-2-<(1S)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl>ethanol
英文别名
(1R)-2-[(1S)-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl]-1-(4-methoxyphenyl)ethanol
(1R)-1-(4-methoxyphenyl)-2-<(1S)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl>ethanol化学式
CAS
——
化学式
C21H27NO4
mdl
——
分子量
357.45
InChiKey
BFMVLFRBLSHGFU-RBUKOAKNSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    26
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    51.2
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    [1-(4-methoxyphenyl)vinyloxy]trimethylsilane 在 palladium on activated charcoal 氢氧化钾ammonium hydroxide氢气 、 trityl tetrafluoroborate 、 四氯化钛 、 sodium cyanoborohydride 、 溶剂黄146 作用下, 以 甲醇二氯甲烷 为溶剂, -78.0~25.0 ℃ 、110.0 kPa 条件下, 反应 172.0h, 生成 (1R)-1-(4-methoxyphenyl)-2-<(1S)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl>ethanol
    参考文献:
    名称:
    2-(1,2,3,4-Tetrahydro-1-isoquinolyl)-乙醇衍生物与 μ 和 κ 受体结合的不对称合成和对映特异性
    摘要:
    许多 2-(1,2,3,4-四氢-1-异喹啉基)-乙醇衍生物 7a-e 已经以非对映体和对映体纯形式合成,并评估了它们对 μ 和 κ 阿片受体的结合亲和力。酰胺酮 5a-c 和 ent-5a-c 可通过将 3b 和 ent-3b 用于不对称亲电酰胺烷基化反应而获得,用作起始化合物。5a-c和ent-5a-c还原得到酰胺醇l-6a-c、u-6a-c、ent-l-6a-c和ent-u-6a-c。这些化合物的水解产生仲氨基醇 l-7a-c、u-7a-c、ent-l-7a-c 和 ent-u-7a-c,并且在 l-7b-c、u-7b 的还原甲基化后—C、ent-l-7b —c 和 ent-u-7b —c 与 CH2O 和 NaCNBH3 叔氨基醇 l-7d-e、u-7d-e、ent-l-7d-e 和 ent-u-得到7d-e。
    DOI:
    10.1002/ardp.19963290104
点击查看最新优质反应信息

文献信息

  • Asymmetric Synthesis and Enantiospecificity of Binding of 2-(1,2,3,4-Tetrahydro-1-isoquinolyl)-ethanol Derivatives to μ and κ Receptors
    作者:Klaus Th. Wanner、Ilona Praschak、Georg Höfner、Herbert Beer
    DOI:10.1002/ardp.19963290104
    日期:——
    reactions, served as starting compounds. Upon reduction of 5a—c and ent‐5a—c the amido alcohols l‐6a—c, u‐6a—c, ent‐l‐6a—c and ent‐u‐6a—c were obtained. Hydrolysis of these compounds yielded the secondary amino alcohols l‐7a—c, u‐7a—c, ent‐l‐7a—c and ent‐u‐7a—c and upon reductive methylation of l‐7b—c, u‐7b—c, ent‐l‐7b—c and ent‐u‐7b—c with CH2O and NaCNBH3 the tertiary amino alcohols l‐7d—e, u‐7d—e, ent‐l‐7d—e
    许多 2-(1,2,3,4-四氢-1-异喹啉基)-乙醇衍生物 7a-e 已经以非对映体和对映体纯形式合成,并评估了它们对 μ 和 κ 阿片受体的结合亲和力。酰胺酮 5a-c 和 ent-5a-c 可通过将 3b 和 ent-3b 用于不对称亲电酰胺烷基化反应而获得,用作起始化合物。5a-c和ent-5a-c还原得到酰胺醇l-6a-c、u-6a-c、ent-l-6a-c和ent-u-6a-c。这些化合物的水解产生仲氨基醇 l-7a-c、u-7a-c、ent-l-7a-c 和 ent-u-7a-c,并且在 l-7b-c、u-7b 的还原甲基化后—C、ent-l-7b —c 和 ent-u-7b —c 与 CH2O 和 NaCNBH3 叔氨基醇 l-7d-e、u-7d-e、ent-l-7d-e 和 ent-u-得到7d-e。
查看更多

同类化合物

1-<2-(4-羟基-3-甲氧基)乙基>-7-羟基-6-甲氧基-1,2,3,4-四氢异喹啉 (1R)-1-(4-methoxyphenyl)-2-<(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl>ethanol (1R)-1-(4-methoxyphenyl)-2-<(1S)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl>ethanol (1S)-1-(4-methoxyphenyl)-2-<(1S)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl>ethanol (1S)-1-(4-methoxyphenyl)-2-<(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl>ethanol Isoautumnaline 6-benzyloxy-1-(3-benzyloxy-4,5-dimethoxyphenethyl)-7-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline 7-Benzyloxy-6-methoxy-2-methyl-1-(4-methoxy-phenethyl)-1,2,3,4-tetrahydro-isochinolin 1-(4-methoxyphenethyl)-1,2,3,4-tetrahydro-6-methoxy-2-methyl-7-isoquinolinol (+)-colchiethine 7-hydroxy-6-methoxy-1-(3',4',5'-trimethoxyphenethyl)-N-methyl-1,2,3,4-tetrahydroisoquinoline (+)-colchiethanamine (+/-)-N,N-Dimethyl-6,7,3',4'-tetramethoxyphenylethyl-1,2,3,4-tetrahydroisoquinolinium iodide [(1S)-7-methoxy-1-[2-(4-methoxyphenyl)ethyl]-2-methyl-3,4-dihydro-1H-isoquinolin-6-yl] 2,2-dimethylpropanoate [4-[2-[(1S)-6-(2,2-dimethylpropanoyloxy)-7-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl]ethyl]phenyl] 2,2-dimethylpropanoate (1S)-6,7-dimethoxy-2-methyl-1-[2-(3,4,5-trimethoxyphenyl)ethyl]-1,2,3,4-tetrahydroisoquinoline (S)-autumnaline 6,7-dimethoxy-1-(4-methoxyphenylethyl)-2-methyl-1,2,3,4-tetrahydroisoquinoline 1,2,3,4-tetrahydro-6-hydroxy-7-methoxy-1-(2-(3',4'-dimethoxyphenyl)ethyl)-2-methylisoquinoline (S)-(+)-homolaudanosine (-)-Homolaudanosine (1R)-1-[2-(4-hydroxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol (1S)-1-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-7-ol (1S)-1-[2-(4-hydroxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-7-ol (1R)-1-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol (1S)-1-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol (S)-1-[2-(4-Hydroxy-phenyl)-ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-7-ol (1R)-1-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-7-ol (1R)-1-[2-(4-hydroxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-7-ol (1S)-1-[2-(4-hydroxy-3,5-dimethoxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol N-Methyl-1-(3,5-dimethoxy-4-hydroxy-phenethyl)-2-methyl-7-hydroxy-6-methoxy-1,2,3,4-tetrahydro-isochinolin (1R)-1-[2-(4-hydroxy-3,5-dimethoxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol (1S)-1-[2-[4-[[(1R)-1-[2-(4-hydroxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]oxy]phenyl]ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol 1-{2-[4-({1-[2-(4-Hydroxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl}oxy)phenyl]ethyl}-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol 1-[2-(4-hydroxyphenyl)ethyl]-7-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-6-ol 7-Hydroxy-1-(3-hydroxy-4,5-dimethoxy-phenethyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydro-isochinolin 7-Hydroxy-1-(4-hydroxy-phenethyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydro-isochinolin, 1-<2-(p-Hydroxy-phenyl)-ethyl>-2-methyl-6-methoxy-7-hydroxy-1,2,3,4-tetrahydro-isochinolin (+/-)-isoautumnaline homolaudanosine 7-methoxy-1-(4-methoxyphenylethyl)-2-methyl-1,2,3,4-tetrahydroisoquinolin-6-ol